CLDX

Celldex Therapeutics (CLDX)

Celldex Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CLDX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	06:34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/15	06:12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/15	05:02	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/14	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/14	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/12	05:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/12	05:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/08	06:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/08	05:57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/08	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/06	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/06	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/06	05:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/05	05:01	GlobeNewswire Inc.	Celldex Therapeutics to Present at Jefferies Healthcare Conference	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/04	06:51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/04	06:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/04	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/04	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/04	05:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/04	05:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/02	22:01	GlobeNewswire Inc.	Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/31	07:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/31	07:01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/31	06:47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/31	04:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/15	21:01	GlobeNewswire Inc.	Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/07	05:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/07	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/07	05:01	GlobeNewswire Inc.	Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/04/17	21:01	GlobeNewswire Inc.	Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria	NASDAQ:CLDX	Celldex Therapeutics Inc